856 related articles for article (PubMed ID: 32529906)
1. Serological differentiation between COVID-19 and SARS infections.
Chia WN; Tan CW; Foo R; Kang AEZ; Peng Y; Sivalingam V; Tiu C; Ong XM; Zhu F; Young BE; Chen MI; Tan YJ; Lye DC; Anderson DE; Wang LF
Emerg Microbes Infect; 2020 Dec; 9(1):1497-1505. PubMed ID: 32529906
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.
Algaissi A; Alfaleh MA; Hala S; Abujamel TS; Alamri SS; Almahboub SA; Alluhaybi KA; Hobani HI; Alsulaiman RM; AlHarbi RH; ElAssouli MA; Alhabbab RY; AlSaieedi AA; Abdulaal WH; Al-Somali AA; Alofi FS; Khogeer AA; Alkayyal AA; Mahmoud AB; Almontashiri NAM; Pain A; Hashem AM
Sci Rep; 2020 Oct; 10(1):16561. PubMed ID: 33024213
[TBL] [Abstract][Full Text] [Related]
3. Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach.
van Tol S; Mögling R; Li W; Godeke GJ; Swart A; Bergmans B; Brandenburg A; Kremer K; Murk JL; van Beek J; Wintermans B; Reimerink J; Bosch BJ; Reusken C
Emerg Microbes Infect; 2020 Dec; 9(1):1965-1973. PubMed ID: 32819220
[TBL] [Abstract][Full Text] [Related]
4. Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays.
DomBourian MG; Annen K; Huey L; Andersen G; Merkel PA; Jung S; Dominguez SR; Knight V
J Immunol Methods; 2020 Nov; 486():112837. PubMed ID: 32828791
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.
Burbelo PD; Riedo FX; Morishima C; Rawlings S; Smith D; Das S; Strich JR; Chertow DS; Davey RT; Cohen JI
J Infect Dis; 2020 Jun; 222(2):206-213. PubMed ID: 32427334
[TBL] [Abstract][Full Text] [Related]
6. Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV.
Ayouba A; Thaurignac G; Morquin D; Tuaillon E; Raulino R; Nkuba A; Lacroix A; Vidal N; Foulongne V; Le Moing V; Reynes J; Delaporte E; Peeters M
J Clin Virol; 2020 Aug; 129():104521. PubMed ID: 32623350
[TBL] [Abstract][Full Text] [Related]
7. Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.
Ripperger TJ; Uhrlaub JL; Watanabe M; Wong R; Castaneda Y; Pizzato HA; Thompson MR; Bradshaw C; Weinkauf CC; Bime C; Erickson HL; Knox K; Bixby B; Parthasarathy S; Chaudhary S; Natt B; Cristan E; El Aini T; Rischard F; Campion J; Chopra M; Insel M; Sam A; Knepler JL; Capaldi AP; Spier CM; Dake MD; Edwards T; Kaplan ME; Scott SJ; Hypes C; Mosier J; Harris DT; LaFleur BJ; Sprissler R; Nikolich-Žugich J; Bhattacharya D
Immunity; 2020 Nov; 53(5):925-933.e4. PubMed ID: 33129373
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
[TBL] [Abstract][Full Text] [Related]
9. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020.
Perera RA; Mok CK; Tsang OT; Lv H; Ko RL; Wu NC; Yuan M; Leung WS; Chan JM; Chik TS; Choi CY; Leung K; Chan KH; Chan KC; Li KC; Wu JT; Wilson IA; Monto AS; Poon LL; Peiris M
Euro Surveill; 2020 Apr; 25(16):. PubMed ID: 32347204
[TBL] [Abstract][Full Text] [Related]
10. A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
Grzelak L; Temmam S; Planchais C; Demeret C; Tondeur L; Huon C; Guivel-Benhassine F; Staropoli I; Chazal M; Dufloo J; Planas D; Buchrieser J; Rajah MM; Robinot R; Porrot F; Albert M; Chen KY; Crescenzo-Chaigne B; Donati F; Anna F; Souque P; Gransagne M; Bellalou J; Nowakowski M; Backovic M; Bouadma L; Le Fevre L; Le Hingrat Q; Descamps D; Pourbaix A; Laouénan C; Ghosn J; Yazdanpanah Y; Besombes C; Jolly N; Pellerin-Fernandes S; Cheny O; Ungeheuer MN; Mellon G; Morel P; Rolland S; Rey FA; Behillil S; Enouf V; Lemaitre A; Créach MA; Petres S; Escriou N; Charneau P; Fontanet A; Hoen B; Bruel T; Eloit M; Mouquet H; Schwartz O; van der Werf S
Sci Transl Med; 2020 Sep; 12(559):. PubMed ID: 32817357
[TBL] [Abstract][Full Text] [Related]
11. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.
Okba NMA; Müller MA; Li W; Wang C; GeurtsvanKessel CH; Corman VM; Lamers MM; Sikkema RS; de Bruin E; Chandler FD; Yazdanpanah Y; Le Hingrat Q; Descamps D; Houhou-Fidouh N; Reusken CBEM; Bosch BJ; Drosten C; Koopmans MPG; Haagmans BL
Emerg Infect Dis; 2020 Jul; 26(7):1478-1488. PubMed ID: 32267220
[TBL] [Abstract][Full Text] [Related]
12. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.
Premkumar L; Segovia-Chumbez B; Jadi R; Martinez DR; Raut R; Markmann A; Cornaby C; Bartelt L; Weiss S; Park Y; Edwards CE; Weimer E; Scherer EM; Rouphael N; Edupuganti S; Weiskopf D; Tse LV; Hou YJ; Margolis D; Sette A; Collins MH; Schmitz J; Baric RS; de Silva AM
Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32527802
[TBL] [Abstract][Full Text] [Related]
13. Correlation of ELISA method with three other automated serological tests for the detection of anti-SARS-CoV-2 antibodies.
Nguyen NN; Mutnal MB; Gomez RR; Pham HN; Nguyen LT; Koss W; Rao A; Arroliga AC; Wang L; Wang D; Hua Y; Powell PR; Chen L; McCormack CC; Linz WJ; Mohammad AA
PLoS One; 2020; 15(10):e0240076. PubMed ID: 33022019
[TBL] [Abstract][Full Text] [Related]
14. A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG.
Zarletti G; Tiberi M; De Molfetta V; Bossù M; Toppi E; Bossù P; Scapigliati G
Viruses; 2020 Nov; 12(11):. PubMed ID: 33171590
[TBL] [Abstract][Full Text] [Related]
15. Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings.
Pickering S; Betancor G; Galão RP; Merrick B; Signell AW; Wilson HD; Kia Ik MT; Seow J; Graham C; Acors S; Kouphou N; Steel KJA; Hemmings O; Patel A; Nebbia G; Douthwaite S; O'Connell L; Luptak J; McCoy LE; Brouwer P; van Gils MJ; Sanders RW; Martinez Nunez R; Bisnauthsing K; O'Hara G; MacMahon E; Batra R; Malim MH; Neil SJD; Doores KJ; Edgeworth JD
PLoS Pathog; 2020 Sep; 16(9):e1008817. PubMed ID: 32970782
[TBL] [Abstract][Full Text] [Related]
16. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs.
Van Elslande J; Decru B; Jonckheere S; Van Wijngaerden E; Houben E; Vandecandelaere P; Indevuyst C; Depypere M; Desmet S; André E; Van Ranst M; Lagrou K; Vermeersch P
Clin Microbiol Infect; 2020 Nov; 26(11):1557.e1-1557.e7. PubMed ID: 32745595
[TBL] [Abstract][Full Text] [Related]
17. False-positive SARS-CoV-2 serology in 3 children with Kawasaki disease.
To KK; Chua GT; Kwok KL; Wong JS; Au DCY; Lam YY; Wong WH; Ho MH; Chan GC; Chui CS; Li X; Tung KT; Wong RS; Tso WW; Wong IC; Wong CS; Fong CH; Chan KH; Yuen KY; Ip P; Kwan MY
Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115141. PubMed ID: 32795776
[TBL] [Abstract][Full Text] [Related]
18. Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome.
Shaw AM; Hyde C; Merrick B; James-Pemberton P; Squires BK; Olkhov RV; Batra R; Patel A; Bisnauthsing K; Nebbia G; MacMahon E; Douthwaite S; Malim M; Neil S; Martinez Nunez R; Doores K; Mark TKI; Signell AW; Betancor G; Wilson HD; Galão RP; Pickering S; Edgeworth JD
Analyst; 2020 Aug; 145(16):5638-5646. PubMed ID: 32638712
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera.
Ha B; Jadhao S; Hussaini L; Gibson T; Stephens K; Salazar L; Ciric C; Taylor M; Rouphael N; Edupuganti S; Rostad CA; Tompkins SM; Anderson EJ; Anderson LJ
Microbiol Spectr; 2021 Oct; 9(2):e0045821. PubMed ID: 34494855
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
